LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

18.26 1.5

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.91

Max

18.71

Belangrijke statistieken
By Trading Economics
Inkomsten	2M -17M
Verkoop	178K 264K
EPS	-0.257
Winstmarge	-6,603.409
Werknemers	116
EBITDA	2M -17M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+67.13% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	16.76
Vorige sluitingsprijs	18.26

Nieuwssentiment

By Acuity

47%

53%

286 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 mrt 2026, 23:39 UTC

Populaire aandelen

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mrt 2026, 23:20 UTC

Winsten

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mrt 2026, 21:43 UTC

Winsten

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mrt 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mrt 2026, 23:24 UTC

Marktinformatie

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mrt 2026, 22:30 UTC

Winsten

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mrt 2026, 22:13 UTC

Winsten

Vermilion Energy 4Q EPS C$2.86 >VET

4 mrt 2026, 22:04 UTC

Marktinformatie

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Rev $66.8M >LAC

4 mrt 2026, 21:53 UTC

Winsten

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mrt 2026, 21:52 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:50 UTC

Winsten

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mrt 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q Rev $165.2M >BULL

4 mrt 2026, 21:48 UTC

Winsten

Webull 4Q EPS 1c >BULL

4 mrt 2026, 21:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 mrt 2026, 21:45 UTC

Marktinformatie

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mrt 2026, 21:40 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:36 UTC

Belangrijke Nieuwsgebeurtenissen

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mrt 2026, 21:27 UTC

Winsten

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mrt 2026, 21:17 UTC

Marktinformatie

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mrt 2026, 21:16 UTC

Winsten

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q EPS $1.50 >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Net $7.35B >AVGO

4 mrt 2026, 21:15 UTC

Winsten

Broadcom 1Q Rev $19.31B >AVGO

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

67.13% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 30 USD 67.13%

Hoogste 30 USD

Laagste 30 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

286 / 352 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.